Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation
NCT: NCT05817318 · TERMINATED
Brief Summary
The aim of this study is to investigate whether renal denervation can reduce arrhythmia burden in patients with recurrent, paroxysmal atrial fibrillation despite durable pulmonary vein isolation.
Frequently Asked Questions
What is Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation?
Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation is a clinical trial registered under NCT05817318. Current status: TERMINATED.
What is the status of NCT05817318?
The current status of NCT05817318 (Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation) is: TERMINATED.
When did Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation start?
Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation started on 2023-06-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.